Combined STAT3 and BCR-ABL1 inhibition induces synthetic lethality in therapy-resistant chronic myeloid leukemia. (Q53741645)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Combined STAT3 and BCR-ABL1 inhibition induces synthetic lethality in therapy-resistant chronic myeloid leukemia. |
scientific article |
Statements
Combined STAT3 and BCR-ABL1 inhibition induces synthetic lethality in therapy-resistant chronic myeloid leukemia. (English)
A M Eiring
B D G Page
I L Kraft
C C Mason
N A Vellore
D Resetca
M S Zabriskie
T Y Zhang
J S Khorashad
A J Engar
K R Reynolds
D J Anderson
A Senina
A D Pomicter
C C Arpin
S Ahmad
W L Heaton
S K Tantravahi
A Todic
R Colaguori
D J Wilson
R Baron
T O'Hare
P T Gunning
M W Deininger
1 May 2017
31
5
1253-1254